These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23153123)

  • 21. Lymphoedema in patients with lentigo maligna treated with imiquimod: a long-term adverse effect.
    Tio D; Kirtschig G; Hoekzema R; van Montfrans C
    Br J Dermatol; 2018 Jun; 178(6):1441-1442. PubMed ID: 29274234
    [No Abstract]   [Full Text] [Related]  

  • 22. Intralesional interferon alfa for treatment of recurrent lentigo maligna of the eyelid in a patient with primary acquired melanosis.
    Carucci JA; Leffell DJ
    Arch Dermatol; 2000 Nov; 136(11):1415-6. PubMed ID: 11074712
    [No Abstract]   [Full Text] [Related]  

  • 23. Serial excision and imiquimod for lentigo maligna melanoma: a proposal for a combined treatment.
    Corneli P; Moscarella E; DI Brizzi EV; Donadio C; Zalaudek I; Alfano R; Argenziano G
    Ital J Dermatol Venerol; 2021 Dec; 156(Suppl. 1 to No. 6):3-4. PubMed ID: 30251811
    [No Abstract]   [Full Text] [Related]  

  • 24. Reply to: A practical guide on the use of imiquimod cream to treat lentigo maligna.
    Muir J; McCormack C; De'Ambrosis B; Brown H; Kennedy D; Louie B; Smithers BM
    Australas J Dermatol; 2022 May; 63(2):e197-e198. PubMed ID: 35262178
    [No Abstract]   [Full Text] [Related]  

  • 25. Progression of lentigo maligna into lentigo maligna melanoma following laser treatment.
    Niiyama N; Niiyama S; Takasu H; Katsuoka K
    Eur J Dermatol; 2007; 17(3):252-3. PubMed ID: 17478397
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of lentigo maligna with the carbon dioxide laser.
    Kopera D
    Arch Dermatol; 1995 Jun; 131(6):735-6. PubMed ID: 7778935
    [No Abstract]   [Full Text] [Related]  

  • 27. Amelanotic lentigo maligna and amelanotic lentigo maligna melanoma: a report of three cases mimicking intraepidermal squamous carcinoma.
    Allan SJ; Dicker AJ; Tidman MJ; McLaren KM; Hunter JA
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):78-81. PubMed ID: 9731974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of lentigo maligna with combination laser therapy: recurrence at 8 months after initial resolution.
    Iyer S; Goldman M
    J Cosmet Laser Ther; 2003 Apr; 5(1):49-52. PubMed ID: 12745600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of imiquimod 3.75% cream for the treatment of solar lentigo.
    Cantisani C; Cantoresi F; Mercuri SR; Binic I; Golubovic M; Marino R; Paolino G
    Dermatol Ther; 2020 Mar; 33(2):e13256. PubMed ID: 32031733
    [No Abstract]   [Full Text] [Related]  

  • 30. Review of management and outcome in 65 patients with lentigo maligna.
    Al-Niaimi F; Jury CS; McLaughlin S; Herd RM
    Br J Dermatol; 2009 Jan; 160(1):211-3. PubMed ID: 19014402
    [No Abstract]   [Full Text] [Related]  

  • 31. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients.
    Schmid-Wendtner MH; Brunner B; Konz B; Kaudewitz P; Wendtner CM; Peter RU; Plewig G; Volkenandt M
    J Am Acad Dermatol; 2000 Sep; 43(3):477-82. PubMed ID: 10954659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spread of a recurrent lentigo maligna into a graft: a case for conservative treatment.
    Davalbhakta A; Hamilton S; Grant JW; Lamberty BG
    Br J Plast Surg; 2001 Apr; 54(3):253-6. PubMed ID: 11254423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lentigo maligna].
    van der Waal RI
    Ned Tijdschr Tandheelkd; 2011 Nov; 118(11):531. PubMed ID: 22235513
    [No Abstract]   [Full Text] [Related]  

  • 34. Hypomyopathic dermatomyositis associated with lentigo maligna melanoma.
    Farrell A; Burnett M; Bohjanen K
    J Am Acad Dermatol; 2006 Jul; 55(1):164-5. PubMed ID: 16781317
    [No Abstract]   [Full Text] [Related]  

  • 35. Lentigo maligna and lentigo maligna melanoma.
    Cohen LM
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):913. PubMed ID: 9204053
    [No Abstract]   [Full Text] [Related]  

  • 36. Lentigo maligna and intensified ablative fractional laser-assisted PDT: a promising, minimally invasive treatment approach.
    Marini L; Marini S
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):440-441. PubMed ID: 32112614
    [No Abstract]   [Full Text] [Related]  

  • 37. Carbon dioxide laser treatment for lentigo maligna: a retrospective review comparing 3 different treatment modalities.
    Lee H; Sowerby LJ; Temple CL; Yu E; Moore CC
    Arch Facial Plast Surg; 2011; 13(6):398-403. PubMed ID: 22106185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Grenz ray treatment of lentigo maligna and early lentigo maligna melanoma.
    Hedblad MA; Mallbris L
    J Am Acad Dermatol; 2012 Jul; 67(1):60-8. PubMed ID: 22030019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lentigo maligna].
    van der Waal RI
    Ned Tijdschr Tandheelkd; 2011 Nov; 118(11):531. PubMed ID: 22235514
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of extensive lentigo maligna melanoma of the scalp by brachytherapy moulage technique.
    Sachse MM; Wagner G; Aydin H; Pohlmann S; Heinicke F; Liebmann A
    Br J Dermatol; 2011 Jan; 164(1):219-21. PubMed ID: 20874783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.